Robert S. Wiesenthal
Director · Strata Critical Medical, Inc.
- 2024
- Aug 3, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert S. Wiesenthal files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Amir Cohen - $410K in SRTA purchases and sales in the last 12 months
- Almir Ambeskovic - $282K in TRIP purchases and sales in the last 12 months
- William A. Heyburn - $186K in SRTA purchases and sales in the last 12 months
- Melissa M. Tomkiel - $175K in SRTA purchases and sales in the last 12 months
- Reginald Love - $125K in SRTA purchases and sales in the last 12 months
- Kristen Ann Dalton - $119K in TRIP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert S. Wiesenthal?
Robert S. Wiesenthal is a corporate insider, tracked as Director of Strata Critical Medical, Inc. (SRTA). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Robert S. Wiesenthal last file a Form 4?
The most recent primary Form 4 on record is dated 3 August 2026, one of 10 filings going back to 2024.
Has Robert S. Wiesenthal been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($6.76M) across all tracked filings.
